President Donald Trump has expressed irritation over Ireland’s role as a major exporter of drugs to the US. Botox users may ...

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...

AbbVie ABBV stock has gained 16.1% so far this year compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

Biotech stocks toppled late Wednesday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on Wednesday from the Rose Garden.

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.

The Publicis Media agency picks up more of the account including its nutrition business from GroupM's Mindshare.

The European Commission has referred Eisai and Biogen’s application to an appeals committee. Elsewhere, Opthea warned of ...

AbbVie’s stock is having a glow-up, climbing 16.1% in 2025, leaving the industry and S&P 500 behind in the dust. The company deftly pivoted after Humira’s fall from patent grace by betting big on ...